PI3K signaling in cancer: beyond AKT

EC Lien, CC Dibble, A Toker - Current opinion in cell biology, 2017 - Elsevier
The phosphoinositide 3-kinase (PI3K) signaling pathway is one of the most frequently
altered pathways in human cancer and has a critical role in driving tumor initiation and …

Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy

S Bono, M Feligioni, M Corbo - Molecular Neurodegeneration, 2021 - Springer
Background Oxidative stress (OS) is an imbalance between oxidant and antioxidant species
and, together with other numerous pathological mechanisms, leads to the degeneration and …

SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway

W Liu, X Wang, Z Liu, Y Wang, B Yin, P Yu… - British journal of …, 2017 - nature.com
Background: Although inhibition of SGK1 has been shown to delay cancer progression, the
underlying mechanisms have not yet been elucidated. Methods: We investigated the cellular …

JNK, p38, ERK, and SGK1 inhibitors in cancer

J Cicenas, E Zalyte, A Rimkus, D Dapkus, R Noreika… - Cancers, 2017 - mdpi.com
Mitogen-activated protein kinases (MAP kinases) are a family of kinases that regulates a
range of biological processes implicated in the response to growth factors like latelet …

SGK1 in human cancer: emerging roles and mechanisms

Y Sang, P Kong, S Zhang, L Zhang, Y Cao… - Frontiers in …, 2021 - frontiersin.org
Serum and glucocorticoid-induced protein kinase 1 (SGK1) is a member of the “AGC”
subfamily of protein kinases, which shares structural and functional similarities with the AKT …

The emerging role of SGK1 (serum-and glucocorticoid-regulated kinase 1) in major depressive disorder: hypothesis and mechanisms

V Dattilo, R Amato, N Perrotti, M Gennarelli - Frontiers in Genetics, 2020 - frontiersin.org
Major depressive disorder (MDD) is a heterogeneous psychiatric disease characterized by
persistent low mood, diminished interests, and impaired cognitive and social functions. The …

SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT

W Liu, X Wang, Y Wang, Y Dai, Y Xie, Y Ping… - Journal of Experimental …, 2018 - Springer
Background Despite SGK1 has been identified and characterized as a tumor-promoting
gene, the functions and underlying mechanisms of SGK1 involved in metastasis regulation …

Autophagy and senescence in cancer therapy

NH Patel, S Bloukh, E Alwohosh, A Alhesa… - Advances in cancer …, 2021 - Elsevier
Tumor cells can undergo diverse responses to cancer therapy. While apoptosis represents
the most desirable outcome, tumor cells can alternatively undergo autophagy and …

RANBP1 (RAN binding protein 1): the missing genetic piece in cancer pathophysiology and other complex diseases

S Audia, C Brescia, V Dattilo, L D'Antona, P Calvano… - Cancers, 2023 - mdpi.com
Simple Summary In just less than 30 years since the cloning of RANBP1 (RAN binding
protein 1), this review represents the first attempt for a comprehensive and analytical …

SGK1 in cancer: Biomarker and drug target

J Cicenas, E Meskinyte-Kausiliene, V Jukna, A Rimkus… - Cancers, 2022 - mdpi.com
Serum-and glucocorticoid-regulated kinases (SGKs) are members of the AGC family of
serine/threonine kinases, consisting of three isoforms: SGK1, SGK2, and SGK3. SGK1 was …